心房颤动患者预防卒中时抗凝治疗的应用不足 - Suppr

Suppr

超能文献

Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation.

作者信息

Piazza Gregory, Karipineni Neelima, Goldberg Howard S, Jenkins Kathryn L, Goldhaber Samuel Z

出版信息

J Am Coll Cardiol. 2016 May 24;67(20):2444-2446. doi: 10.1016/j.jacc.2016.03.515.

DOI:10.1016/j.jacc.2016.03.515

PMID:27199068

Abstract

摘要

相似文献

Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation.心房颤动患者预防卒中时抗凝治疗的应用不足

J Am Coll Cardiol. 2016 May 24;67(20):2444-2446. doi: 10.1016/j.jacc.2016.03.515.

[Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].[心房颤动相关性卒中患者口服抗凝药使用不足的原因：德国卒中患者的前瞻性研究]

Fortschr Neurol Psychiatr. 2008 Jul;76(7):391-5. doi: 10.1055/s-2008-1038216.

Anticoagulation for atrial fibrillation: underutilization in a Brazilian tertiary outpatient clinic.

Clin Cardiol. 2004 Nov;27(11):592-3.

Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study.心房颤动患者中风的危险因素及血栓预防：日常临床实践中情况如何？GEFAUR-1研究。

Ann Emerg Med. 2004 Jul;44(1):3-11. doi: 10.1016/S0196064404000587.

Prevalence of stroke and the need for thromboprophylaxis in young patients with atrial fibrillation: a cohort study.年轻心房颤动患者中风的患病率和血栓预防的需求：一项队列研究。

J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):189-93. doi: 10.2459/JCM.0b013e3283654c4b.

[Characterisation of thromboembolic risk in a mexican population with non-valvular atrial fibrillation and its effect on anticoagulation (MAYA Study)].[墨西哥非瓣膜性心房颤动人群血栓栓塞风险的特征及其对抗凝治疗的影响（玛雅研究）]

Gac Med Mex. 2016 Jul-Aug;152(4):473-8.

New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.新型抗凝剂（达比加群、阿哌沙班、利伐沙班）用于预防房颤卒中。

Neurol Clin. 2013 Aug;31(3):659-75. doi: 10.1016/j.ncl.2013.03.001.

Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.在华法林时代之后，韩国心房颤动患者的中风预防措施不足。

Int J Cardiol. 2016 Oct 1;220:647-52. doi: 10.1016/j.ijcard.2016.06.177. Epub 2016 Jun 25.

[New oral anticoagulants in patients with atrial fibrillation in a urban health center].[城市医疗中心心房颤动患者的新型口服抗凝剂]

Med Clin (Barc). 2016 Mar 18;146(6):280-1. doi: 10.1016/j.medcli.2015.06.016. Epub 2015 Sep 4.

Atrial fibrillation, stroke and anticoagulation.心房颤动、中风与抗凝治疗

J Assoc Physicians India. 2002 Sep;50:1153-8.

引用本文的文献

J Gen Intern Med. 2024 Dec;39(16):3234-3242. doi: 10.1007/s11606-024-08871-y. Epub 2024 Jun 27.

Effect of clinic-based single-lead electrocardiogram rhythm assessment on oral anticoagulation prescriptions in patients with previously diagnosed atrial fibrillation.基于临床的单导联心电图节律评估对既往诊断为心房颤动患者口服抗凝药物处方的影响。

Heart Rhythm O2. 2023 Jul 12;4(8):469-477. doi: 10.1016/j.hroo.2023.07.003. eCollection 2023 Aug.

Mendelian randomization study on atrial fibrillation and cardiovascular disease subtypes.心房颤动与心血管疾病亚型的孟德尔随机化研究

Sci Rep. 2021 Sep 21;11(1):18682. doi: 10.1038/s41598-021-98058-w.

The role of biomarkers and neuroimaging in ischemic/hemorrhagic risk assessment for cardiovascular/cerebrovascular disease prevention.生物标志物和神经影像学在心血管/脑血管疾病预防中的缺血/出血风险评估中的作用。

Handb Clin Neurol. 2021;177:345-357. doi: 10.1016/B978-0-12-819814-8.00021-4.

Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation.心房颤动中的抗血小板处方：与低抗凝率的关联

TH Open. 2018 Jun 7;2(2):e229-e232. doi: 10.1055/s-0038-1660506. eCollection 2018 Apr.

Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation.住院心房颤动患者的抗凝治疗与死亡率

TH Open. 2018 Jan 30;2(1):e33-e38. doi: 10.1055/s-0038-1626732. eCollection 2018 Jan.

Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation.阶梯式随机临床试验，旨在评估旨在增加心房颤动患者适当抗凝治疗的人群健康干预措施。

BMJ Qual Saf. 2019 Oct;28(10):835-842. doi: 10.1136/bmjqs-2019-009367. Epub 2019 Jun 26.

Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial.电子医生通知改善房颤基于指南的抗凝治疗：一项随机对照试验。

J Gen Intern Med. 2018 Dec;33(12):2070-2077. doi: 10.1007/s11606-018-4612-6. Epub 2018 Aug 3.

Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation With Direct Oral Anticoagulants. Is One Of These Not Like The Others?使用直接口服抗凝剂降低非瓣膜性心房颤动患者的中风风险。这些药物中有不一样的吗？

J Atr Fibrillation. 2016 Aug 31;9(2):1481. doi: 10.4022/jafib.1481. eCollection 2016 Aug-Sep.

Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age.心房颤动合并肾功能损害、体重过轻或过重或高龄患者使用直接口服抗凝剂的情况。

Clin Cardiol. 2017 Jan;40(1):46-52. doi: 10.1002/clc.22591. Epub 2016 Oct 7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验